• Aberdeen University Featured PhD Programmes
  • FindA University Ltd Featured PhD Programmes
  • University of Tasmania Featured PhD Programmes
  • University of Cambridge Featured PhD Programmes
  • University of Leeds Featured PhD Programmes
  • University of Pennsylvania Featured PhD Programmes
  • Staffordshire University Featured PhD Programmes
University of Tasmania Featured PhD Programmes
University of Leeds Featured PhD Programmes
EPSRC Featured PhD Programmes
Imperial College London Featured PhD Programmes
FindA University Ltd Featured PhD Programmes

Structure and function of the platelet receptor Ib receptor. Opening doors to novel treatments for stroke.

This project is no longer listed in the FindAPhD
database and may not be available.

Click here to search the FindAPhD database
for PhD studentship opportunities
  • Full or part time
    Dr Emsley
  • Application Deadline
    No more applications being accepted
  • Self-Funded PhD Students Only
    Self-Funded PhD Students Only

Project Description

Ischemic stroke is a devastating disease that represents the primary reason for sustained disability and the second leading cause of death worldwide. A better understanding of underlying molecular mechanisms of the disease are required to develop new treatment strategies. The interaction between platelet glycoprotein Iba (GpIbα) and von Willebrand factor (vWF) bound to damaged sub-endothelium represents the first step in platelet adhesion and is essential for normal hemostasis and vascular repair. The interaction is mediated between the N-terminal ligand-binding domain of GpIbα and the vWF-A1 domain and is markedly enhanced as hydrodynamic shear increases, due to conformational activation of vWF or GpIbα or both. In pathological situations, such as stroke or myocardial infarction, vascular damage and enhanced shear rates occurring in stenosised arteries can cause inappropriate activation, GpIbα-vWF binding contributing to thrombus formation. This project involves studying the molecular structure of the three proteins which form the GPIb complex (GPIba,GPIbb,GPIX) in complex with a key co-factor to coagulation enzyme and cell receptor function high molecular weight kininogen.
The Emsley group solved the first crystal structure of the GPIb N-terminal domain and an inhibitor complex (Blood.2009;114(23):4883-5). JE group subsequently described the structural organisation of the receptor and the molecular basis of the rare platelet disorder BSS (Blood.2011;118(19):5292-301). More recently through collaboration a peptide anti-GPIb approach was demonstrated in a mouse model of thrombosis (Blood.2014;124(25):3799-807). Experimental evidence suggests that GPIb is a critical pathogenic factor in innate immune inflammation in the brain. Ultimately the holy grail of my research is a greater overall understanding of GPIb assembly, regulation, and a more complete description of GPIb ligand and inhibitor interactions. This will provide a toolkit to open doors in establishing structure-function relationships and probe mechanism of brain disease (JournalofCerebralBloodFlow&Metabolism (2012)32,1831–1840)

http://www.nottingham.ac.uk/research/groups/structural-biology/index.aspx

Funding Notes

This project is open to UK, EU students and international students who are self funded.

How good is research at University of Nottingham in Allied Health Professions, Dentistry, Nursing and Pharmacy?
Pharmacy

FTE Category A staff submitted: 44.10

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities
Share this page:

Cookie Policy    X